Article Text

Download PDFPDF
Is MOG-IgG another biomarker for neuromyelitis optica?
  1. Ichiro Nakashima
  1. Correspondence to Dr Ichiro Nakashima, Department of Neurology, Tohoku Medical and Pharmaceutical University, 1-12-1 Fukumuro, Miyagino-ku, Sendai 983-8512, Japan; nakashima{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Anti-myelin oligodendrocyte glycoprotein antibody can be detected in NMOSD phenotype of CNS inflammatory diseases negative for anti-aquaporin-4 antibody

Myelin oligodendrocyte glycoprotein (MOG) is a glycoprotein exclusively expressed on the surface of the myelin sheath in the central nervous system (CNS). Although the precise function of MOG is yet unknown, it is possibly related to the maintenance of the myelin structure. MOG has been of great interest because of its association with demyelinating diseases, particularly in multiple sclerosis (MS). It has also been used as an antigen to induce experimental autoimmune encephalomyelitis (EAE) in rodents as an animal model of MS. EAE induced by MOG peptides may develop inflammatory demyelinating CNS lesions dominantly in the optic nerves and the spinal cord. Although …

View Full Text


  • Contributors The author wrote the commentary solely.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles